Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DELTA study of oral dexamethasone for mild to moderate COVID-19
ACTRN12621001200875Phase 2Recruiting
- Sponsor
- Royal Prince Alfred Hospital
- Start
- Sep 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of dexamethasone and thiamine in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Royal Prince Alfred Hospital. Primary endpoint: COVID-19 related hospitalization composite. Started Sep 2021; status: recruiting.
02
Drugs
dexamethasonethiamine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on ACTRN12621001200875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621001200875.